Article in NAR molecular medicine, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
2 · The registry
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Joshua J CorriganDepartment of Biological Engineering, Massachusetts Institute of Technology, Cambridge, MA 02139, United States.ORCID https://orcid.org/0009-0006-6252-4960
Esha D DalvieDepartment of Biological Engineering, Massachusetts Institute of Technology, Cambridge, MA 02139, United States.
Monét NoralesDepartment of Biological Engineering, Massachusetts Institute of Technology, Cambridge, MA 02139, United States.
Nicolette A BugherCenter for Environmental Health Sciences, Massachusetts Institute of Technology, Cambridge, MA 02139, United States.
Kayla M SchonviskyDepartment of Biological Engineering, Massachusetts Institute of Technology, Cambridge, MA 02139, United States.
Desiree L PlataCenter for Environmental Health Sciences, Massachusetts Institute of Technology, Cambridge, MA 02139, United States.
Bevin P EngelwardDepartment of Biological Engineering, Massachusetts Institute of Technology, Cambridge, MA 02139, United States.ORCID https://orcid.org/0000-0003-4322-3573
Robert G CroyDepartment of Biological Engineering, Massachusetts Institute of Technology, Cambridge, MA 02139, United States.
TOXICOLOGY CORE UNITP30ES002109 · NIEHS · MASSACHUSETTS INSTITUTE OF TECHNOLOGY · PI NILES, JACQUIN C · 1985 to 2020
$25.6M
The MIT Superfund Research Program: A Systems Approach for the Protection of Human Health from Hazardous ChemicalsP42ES027707 · NIEHS · MASSACHUSETTS INSTITUTE OF TECHNOLOGY · PI Stuart S Levine · 2017 to 2026
$22.2M
TRAINING GRANTS IN ENVIROMENTAL TOXICOLOGYT32ES007020 · NIEHS · MASSACHUSETTS INSTITUTE OF TECHNOLOGY · PI ESSIGMANN, JOHN M · 1985 to 2024
$13.1M
Intra and Extra-Chromosomal Probes for Mutagenesis by CarcinogensR01CA080024 · NCI · MASSACHUSETTS INSTITUTE OF TECHNOLOGY · PI ESSIGMANN, JOHN M · 1998 to 2025
$5.9M
Cross-Disciplinary Research Training for Veterinary StudentsT35OD033655 · OD · TUFTS UNIVERSITY BOSTON · PI Cheryl A London, Kelly Ann Metcalf Pate · 2022 to 2026
$459k
Leveraging mutational analysis of cell-free DNA to identify carcinogenic exposure and enable early detection of cancerR21ES036341 · NIEHS · MASSACHUSETTS INSTITUTE OF TECHNOLOGY · PI FEDELES, BOGDAN I · 2024 to 2025
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.
DNA adduct and mutational profiles reveal a threshold of cellular defenses against · full record | OpenQuestion